Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation
- PMID: 11108241
- DOI: 10.1210/endo.141.12.7858
Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation
Abstract
The GH binding protein (GHBP), which exists in many vertebrates, is a circulating high affinity binding protein corresponding to the extracellular domain of the GH receptor (GHR). In humans, rabbits, and several other species, the GHBP is generated by proteolysis of the GHR and shedding of its extracellular domain. We previously showed that GHBP shedding is inducible by the phorbol ester phorbol 12-myristate,13-acetate (PMA) and inhibited by the metalloprotease inhibitor, Immunex Corp. Compound 3 (IC3). The metzincin metalloprotease, tumor necrosis factor-alpha (TNF-alpha)-converting enzyme (TACE), catalyzes the shedding of TNF-alpha from its transmembrane precursor, a process that is also inhibitable by IC3. TACE may hence be a candidate for GHBP sheddase. In this study, we reconstitute fibroblasts derived from a TACE knockout mouse (Null cells) with either the rabbit (rb) GHR alone (Null/R) or rbGHR plus murine TACE (Null/R+T). Although GHR in both cells was expressed at similar abundance, dimerized normally and caused JAK2 activation in response to GH independent of TACE expression, PMA was unable to generate GHBP from Null/R cells. In contrast, PMA caused ample GHBP generation from TACE reconstituted (Null/R + T) cells, and this GHBP shedding was substantially inhibited by IC3 pretreatment. Corresponding to the induced shedding of GHBP from Null/R + T cells, PMA treatment caused a significant loss of immunoblottable GHR in Null/R+T, but not in Null/R cells. We conclude that TACE is an enzyme required for PMA-induced GHBP shedding and that PMA-induced down-regulation of GHR abundance may in significant measure be attributable to TACE-mediated GHR proteolysis.
Similar articles
-
Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: relationship to GH receptor down-regulation.Endocrinology. 2001 Mar;142(3):1137-47. doi: 10.1210/endo.142.3.8030. Endocrinology. 2001. PMID: 11181529
-
Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site.J Biol Chem. 2002 Dec 27;277(52):50510-9. doi: 10.1074/jbc.M208738200. Epub 2002 Oct 25. J Biol Chem. 2002. PMID: 12403792
-
Blockade of growth hormone receptor shedding by a metalloprotease inhibitor.Endocrinology. 1998 Apr;139(4):1927-35. doi: 10.1210/endo.139.4.5906. Endocrinology. 1998. PMID: 9528979
-
Metalloproteinases and the modulation of GH signaling.J Endocrinol. 2002 Sep;174(3):361-8. doi: 10.1677/joe.0.1740361. J Endocrinol. 2002. PMID: 12208655 Review.
-
Growth hormone binding protein. The soluble growth hormone receptor.Minerva Endocrinol. 2002 Dec;27(4):265-76. Minerva Endocrinol. 2002. PMID: 12511849 Review.
Cited by
-
Phosphorylation of the JAK2-STAT5 pathway in response to acute aerobic exercise.Med Sci Sports Exerc. 2008 Jun;40(6):1031-8. doi: 10.1249/MSS.0b013e3181690760. Med Sci Sports Exerc. 2008. PMID: 18461004 Free PMC article.
-
Classical and novel GH receptor signaling pathways.Mol Cell Endocrinol. 2020 Dec 1;518:110999. doi: 10.1016/j.mce.2020.110999. Epub 2020 Aug 22. Mol Cell Endocrinol. 2020. PMID: 32835785 Free PMC article. Review.
-
Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action.PLoS One. 2012;7(4):e34787. doi: 10.1371/journal.pone.0034787. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545089 Free PMC article.
-
Recent advances in growth hormone signaling.Rev Endocr Metab Disord. 2006 Dec;7(4):225-35. doi: 10.1007/s11154-007-9025-5. Rev Endocr Metab Disord. 2006. PMID: 17308965 Review.
-
Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.Front Endocrinol (Lausanne). 2020 Nov 18;11:597573. doi: 10.3389/fendo.2020.597573. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33312162 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous